- Home
- INSE vs ACIU Comparison
INSE vs ACIU Comparison
Compare INSE & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSE | ACIU |
|---|---|---|
| Founded | 2002 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.2M | 213.3M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | INSE | ACIU |
|---|---|---|
| Price | $8.64 | $3.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $13.40 | $10.00 |
| AVG Volume (30 Days) | 83.3K | ★ 418.4K |
| Earning Date | 03-16-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $309,900,000.00 | $5,482,957.00 |
| Revenue This Year | $4.09 | N/A |
| Revenue Next Year | N/A | $644.42 |
| P/E Ratio | $4.49 | ★ N/A |
| Revenue Growth | ★ 4.98 | N/A |
| 52 Week Low | $6.51 | $1.43 |
| 52 Week High | $11.61 | $4.00 |
Technical Indicators
Market Signals| Indicator | INSE | ACIU |
|---|---|---|
| Relative Strength Index (RSI) | 40.59 | 48.98 |
| Support Level | $8.51 | $3.24 |
| Resistance Level | $9.48 | $3.90 |
| Average True Range (ATR) | 0.42 | 0.25 |
| MACD | -0.11 | -0.03 |
| Stochastic Oscillator | 11.46 | 19.70 |
Price Performance
Historical ComparisonAbout INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments, namely Gaming, Virtual Sports, Interactive, and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.